Evidence map›Paper›PMID 28253422›Full record

ReviewBritish journal of pharmacology2017

Plant sterol enriched functional food and atherosclerosis.

Jürgen Köhler, Daniel Teupser, Albrecht Elsässer, Oliver Weingärtner

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Nonalcoholic Fatty Liver Disease.Handbook of experimental pharmacology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. 5Oxidative medicine and cellular longevity · 2019
    Article
  16. Nutraceuticals as therapeutic agents for atherosclerosis.Biochimica et biophysica acta. Molecular basis of disease · 2018
    Review
  17. Review
  18. Principles of pharmacological research of nutraceuticals.British journal of pharmacology · 2017
    Article
  19. Plant sterol enriched functional food and atherosclerosis.British journal of pharmacology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jürgen KöhlerClinic for Thorax-, Vascular and Endovascular Surgery, Pius-Hospital Oldenburg, Carl von Ossietzky Universität, Oldenburg, Germany.
Daniel TeupserInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Albrecht ElsässerDepartment of Cardiology, Klinikum Oldenburg, European Medical School Oldenburg-Groningen, Carl von Ossietzky University, Oldenburg, Germany.
Oliver WeingärtnerDepartment of Cardiology, Klinikum Oldenburg, European Medical School Oldenburg-Groningen, Carl von Ossietzky University, Oldenburg, Germany.ORCID 0000-0002-0236-206X
Klinikum Oldenburg · DECarl von Ossietzky Universität Oldenburg · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypercholesterolaemia is a major cardiovascular risk factor. A healthy diet and a healthy lifestyle reduces cardiovascular risk. 'Functional foods' supplemented with phytosterols are recommended for the management of hypercholesterolaemia and have become a widely used non-prescription approach to lower plasma cholesterol levels. Two billion euros are spent world-wide each year on various functional foods, which have regulator-approved health claims for the management of elevated cholesterol levels. While international societies, such as the European Atherosclerosis Society or the National Heart Foundation in Australia, still advise phytosterols as an additional dietary option in the management of hypercholesterolaemia, recently released guidelines such as those from the National Institute of Health and Clinical Excellence in the United Kingdom are more critical of food supplementation with phytosterols and draw attention to significant safety issues. This review challenges whether an intervention with phytosterol supplements is beneficial. We summarize the current evidence from genetic diseases, genetic association studies, clinical trial data and data from animal studies. LINKED ARTICLES: This article is part of a themed section on Principles of Pharmacological Research of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.11/issuetoc.

Indexed as

Functional FoodAnimalsAtherosclerosisCardiovascular DiseasesDietary SupplementsHumansHypercholesterolemiaPhytosterolsPractice Guidelines as TopicRisk FactorsPhytosterols

Identifiers

PMID28253422
PMCPMC5429322
OpenAlexW2591582720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.